Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence.


Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
04 2021
Historique:
received: 08 06 2020
revised: 06 02 2021
accepted: 08 02 2021
pubmed: 28 2 2021
medline: 30 10 2021
entrez: 27 2 2021
Statut: ppublish

Résumé

Adherence to medications for asthma and COPD can reduce exacerbation rates, decrease healthcare costs, and improve health-related quality of life. In spite of the advantages to treatment adherence, individuals with asthma and COPD often fail to take medicines as prescribed. The objectives of this study were to determine the extent of non-adherence with asthma and COPD medicines and to describe the reasons for non-adherence in these conditions. Data from the National Health and Wellness Study (NHWS), a self-administered, annual, internet-based cross-sectional survey of US adults from 2018 was used. NHWS participants who self-reported taking daily prescription medication(s) to treat asthma and COPD responded to the 19 reasons for non-adherence and one global item in the Medication Adherence Reasons Scale (MAR-Scale). Frequencies were used to identify the reasons for non-adherence. The non-adherence rate in asthma (N = 2810) was 38.4% and 28.4% in COPD (N = 1632). For both conditions, "simply missing the medicine" was the most common cause of non-adherence. Additionally, for both conditions, there was a difference between the non-adherence reason reported by more individuals and the reason for which the medicine was missed for the most number of days. The MAR-Scale identified the most frequent reasons for non-adherence with asthma and COPD in a nationwide sample in the US. The MAR-Scale can be used as a tool in a clinic setting or at a population level to measure the extent and the reasons for non-adherence.

Identifiants

pubmed: 33639405
pii: S0954-6111(21)00043-3
doi: 10.1016/j.rmed.2021.106337
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106337

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Elizabeth J Unni (EJ)

Touro College of Pharmacy, 230 West 125th Street, New York, NY, 10027, United States. Electronic address: Elizabeth.unni@touro.edu.

Shaloo Gupta (S)

Kantar, 3 World Trade Center, 175 Greenwich St, 35th Floor, New York, NY, 10007, United States. Electronic address: Shaloo.Gupta@kantar.com.

Nikoletta Sternbach (N)

Kantar, 3 World Trade Center, 175 Greenwich St, 35th Floor, New York, NY, 10007, United States. Electronic address: Nikoletta.Sternbach@kantar.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH